Table 4 Univariable Cox regression on progression-free survival.

From: The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma

parameter

N

Events

level

ref

HR

LCL

UCL

Waldp

LRTp

Gal3 (binary)

119

29

pos

neg

1,7

0,59

4,89

0.327

0.297

Gal3 (IG)*

119

29

0.5

0

1,97

0,55

7

0.297

0.373

1

0

2,58

0,57

11,66

0.219

2

0

2,35

0,72

7,66

0.158

3

0

1,07

0,31

3,64

0.920

Grade

111

28

G2

G1

3,97

0,54

29,37

0.177

0.031

G3

G1

12,86

1,42

116,38

0.023

T Stage

119

29

pT2

pT1

2,96

0,94

9,35

0.064

 < 0.001

pT3/4

pT1

7,39

3,02

18,09

 < 0.001

Histology

119

29

pRCC

ccRCC

0,45

0,11

1,9

0.278

0.347

chRCC

ccRCC

0,45

0,06

3,3

0.429

V status

119

29

1

0

6,77

3,03

15,12

 < 0.001

 < 0.001

2

0

5,6

1,59

19,73

0.007

N status

119

29

1

0

9,32

3,45

25,16

 < 0.001

 < 0.001

M status

119

29

M1

M0

21,4

8,01

57,15

 < 0.001

 < 0.001

RSF*

119

29

1

0

4,87

1,66

14,32

0.004

0.016

R status

116

28

1/2

0

5,63

1,92

16,48

0.002

0.009

L status

119

29

1

0

9,83

3,24

29,83

 < 0.001

0.001

  1. *IG intensity grade, RSF renal sinus fat infiltration, HR hazard ratio, LCL/UCL lower/upper 95% confidence limits, Waldp p-value of Wald test, LRTp p-value of likelihood-ratio test.
Back to article page